Skip to main content

Table 2 Descriptive information on datasets extracted from the GEO database used in this study.

From: An indicator of cancer: downregulation of Monoamine Oxidase-A in multiple organs and species

Human Independent Samples (Case-control)

GSE Number

GEO Description

Species

Control (N)

Cancer Type (N)

Mean Fold Difference in MAO-A

p-value

Percentage of cancer samples < lowest control

GSE3189

Cutaneous malignant melanoma

H

Normal (7)

Malignant Melanoma (45)

-15.0

4.9*10-21

100%

GSE1037

Lung neuroendocrine tumor classification

H

Normal Lung (19)

Small Cell lung Carcinoma (15)

-9.7

1.1*10-10

100%

GSE2549*

Human Malignant Pleural Mesothelioma

H

Normal Pleura (5)

Malignant pleural mesothelioma (40)

-7.4

4.6*10-10

90%

GSE61

Breast tumor characterization

H

Normal Breast (10)

Basal-like Tumors (10)

-5.6

1.6*10-4

100%

GSE2379

Hypopharyngeal cancer at various stages of progression

H

Normal Uvula (3)

Early Stage (4)

-3.4

7.7*10-4

100%

GSE3744

Basal-like breast cancer tumors

H

Normal Breast (7)

Basal-like Cancer (18)

-5.7

0.002

88%

* Lung tissue and cell lines were excluded. Only primary tumor samples and normal pleura were analyzed.

Paired Samples

GEO Series Number

Cancer Type

Species

Control (N)

Cancer (N)

Fold Difference in MAO-A

p-value

Percentage

GSE3268

Human Squamous Cell Carcinoma of the lung

H

Control (5)

Cancer (5)

-2.7

0.001

100%

GSE781

Clear Cell Carcinoma of the human kidney

H

Normal (7)

Renal clear Cell Carcinoma (7)

-2.2

0.002

100%

GSE2514

Pulmonary adenocarcinoma

H

Adjacent Normal (10)

Tumor (10)

-1.7

0.004

80%

GSE2685**

Gastric cancer

H

Normal (6)

Cancer (6)

-3.6

0.03§

100%

GSE3678

Papillary thyroid cancer

H

Normal (7)

Papillary thyroid Cancer (7)

-1.2

0.08§

71%

GSE3467

Papillary thyroid cancer

H

Normal (9)

Papillary thyroid Carcinoma (9)

-1.1

0.286§

67%

**Paired data was extracted and unpaired samples were excluded.

Animal Models

GEO Series Number

Cancer Type

Species

Control (N)

Cancer (N)

Fold Difference in MAO-A

p-value

Percentage

GSE2514

Urethane-induced lung tumor model of pulmonary adenocarcinoma

M

Adjacent Normal (10)

Tumor (29)

-1.7

6.6*10-10

86%

GSE3519***

Liver cancer model

Z

Normal Liver Tissue (10)

Liver Tumor (10)

-2.2

1.7*10-5

100%

GSE3348

LH overexpressing virgin mice (luteinizing hormone overexpression causes spontaneous mammary tumors)

M

Wild type Breast tissue (3)

LH-overexpressing Breast tissue (3)

-1.7

5.9*10-5

100%

GSE2426

Patched heterozygous model of medulloblastoma

M

Granule cell Precursor (4)

Tumor Cells from Heterozygotes (5)

-1.6

6.9*10-5

100%

GSE422

Colon cancer

M

C57/BL6 wild-type (6)

APC(Min/+) mutant (10)

-18.9

1.1*10-4

100%

GSE1872****

N-methyl-N-nitrosourea-induced breast cancer model (R)

R

Normal (11)

Cancer (9)

-1.7

5.9*10-5

100%

GSE2528

Mammary tumorigenesis in MMTV-neu model

M

Wild type Normal Breast (3)

Mammary tumors in MMTV-neu Model (7)

-1.8

0.001

100%

  1. *** Zebrafish do not have separate MAO-A and MAO-B therefore MAO levels were analyzed.
  2. **** Biological replicates were averaged for the analysis.
  3. Descriptive information on datasets extracted from the GEO database used in this study. Cases are grouped by whether control and cancer tissues came from different human patients (independent samples), the same human patients (paired samples), or animal models. Tissues are from humans (H) mice (Mus musculus, M), rats (Rattus norvegicus, R), or zebrafish (Danio rerio, Z). For each dataset, sample sizes of control and cancer tissues are provided. The fold difference in mean intensities of MAO-A describes the amount of suppression of the expression of that gene in cancerous tissue; for example, a fold difference of -4 indicates 4 times less expression in cancer tissue than in normal tissue. P-values reflect significant fold differences in expression between cancer and control tissues using the appropriate t-test; cancer types are listed in order of decreasing significance of MAO-A expression. All datasets showed a significant change as determined by the sequential Bonferoni-Holm adjustment unless marked § The percentage column contains the percent of individual cancer tissue samples in each data set that had lower levels of MAO-A expression than the lowest single control sample.